Toll Like Receptor 8 Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: T84C62B941AAEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Toll Like Receptor 8 in Global, including the following market information:

Global Toll Like Receptor 8 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Toll Like Receptor 8 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

JB-6121 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Toll Like Receptor 8 include AstraZeneca Plc, Celgene Corp, Dynavax Technologies Corp, Eisai Co Ltd, Galderma SA, Gilead Sciences Inc, Idera Pharmaceuticals Inc, Janus Biotherapeutics Inc and MedImmune LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Toll Like Receptor 8 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Toll Like Receptor 8 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Toll Like Receptor 8 Market Segment Percentages, by Type, 2021 (%)

• JB-6121
• IMO-8400
• E-6742
• DV-1001
• Others

Global Toll Like Receptor 8 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Toll Like Receptor 8 Market Segment Percentages, by Application, 2021 (%)

• Allergic Rhinitis
• Colon Cancer
• Hepatitis B
• Peritoneal Cancer
• Others

Global Toll Like Receptor 8 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Toll Like Receptor 8 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Toll Like Receptor 8 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Toll Like Receptor 8 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca Plc
• Celgene Corp
• Dynavax Technologies Corp
• Eisai Co Ltd
• Galderma SA
• Gilead Sciences Inc
• Idera Pharmaceuticals Inc
• Janus Biotherapeutics Inc
• MedImmune LLC
• Nektar Therapeutics
• Vivelix Pharmaceuticals Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Toll Like Receptor 8 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Toll Like Receptor 8 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TOLL LIKE RECEPTOR 8 OVERALL MARKET SIZE

2.1 Global Toll Like Receptor 8 Market Size: 2021 VS 2028
2.2 Global Toll Like Receptor 8 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Toll Like Receptor 8 Players in Global Market
3.2 Top Global Toll Like Receptor 8 Companies Ranked by Revenue
3.3 Global Toll Like Receptor 8 Revenue by Companies
3.4 Top 3 and Top 5 Toll Like Receptor 8 Companies in Global Market, by Revenue in 2021
3.5 Global Companies Toll Like Receptor 8 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Toll Like Receptor 8 Players in Global Market
  3.6.1 List of Global Tier 1 Toll Like Receptor 8 Companies
  3.6.2 List of Global Tier 2 and Tier 3 Toll Like Receptor 8 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Toll Like Receptor 8 Market Size Markets, 2021 & 2028
  4.1.2 JB-6121
  4.1.3 IMO-8400
  4.1.4 E-6742
  4.1.5 DV-1001
  4.1.6 Others
4.2 By Type - Global Toll Like Receptor 8 Revenue & Forecasts
  4.2.1 By Type - Global Toll Like Receptor 8 Revenue, 2017-2022
  4.2.2 By Type - Global Toll Like Receptor 8 Revenue, 2023-2028
  4.2.3 By Type - Global Toll Like Receptor 8 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Toll Like Receptor 8 Market Size, 2021 & 2028
  5.1.2 Allergic Rhinitis
  5.1.3 Colon Cancer
  5.1.4 Hepatitis B
  5.1.5 Peritoneal Cancer
  5.1.6 Others
5.2 By Application - Global Toll Like Receptor 8 Revenue & Forecasts
  5.2.1 By Application - Global Toll Like Receptor 8 Revenue, 2017-2022
  5.2.2 By Application - Global Toll Like Receptor 8 Revenue, 2023-2028
  5.2.3 By Application - Global Toll Like Receptor 8 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Toll Like Receptor 8 Market Size, 2021 & 2028
6.2 By Region - Global Toll Like Receptor 8 Revenue & Forecasts
  6.2.1 By Region - Global Toll Like Receptor 8 Revenue, 2017-2022
  6.2.2 By Region - Global Toll Like Receptor 8 Revenue, 2023-2028
  6.2.3 By Region - Global Toll Like Receptor 8 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Toll Like Receptor 8 Revenue, 2017-2028
  6.3.2 US Toll Like Receptor 8 Market Size, 2017-2028
  6.3.3 Canada Toll Like Receptor 8 Market Size, 2017-2028
  6.3.4 Mexico Toll Like Receptor 8 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Toll Like Receptor 8 Revenue, 2017-2028
  6.4.2 Germany Toll Like Receptor 8 Market Size, 2017-2028
  6.4.3 France Toll Like Receptor 8 Market Size, 2017-2028
  6.4.4 U.K. Toll Like Receptor 8 Market Size, 2017-2028
  6.4.5 Italy Toll Like Receptor 8 Market Size, 2017-2028
  6.4.6 Russia Toll Like Receptor 8 Market Size, 2017-2028
  6.4.7 Nordic Countries Toll Like Receptor 8 Market Size, 2017-2028
  6.4.8 Benelux Toll Like Receptor 8 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Toll Like Receptor 8 Revenue, 2017-2028
  6.5.2 China Toll Like Receptor 8 Market Size, 2017-2028
  6.5.3 Japan Toll Like Receptor 8 Market Size, 2017-2028
  6.5.4 South Korea Toll Like Receptor 8 Market Size, 2017-2028
  6.5.5 Southeast Asia Toll Like Receptor 8 Market Size, 2017-2028
  6.5.6 India Toll Like Receptor 8 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Toll Like Receptor 8 Revenue, 2017-2028
  6.6.2 Brazil Toll Like Receptor 8 Market Size, 2017-2028
  6.6.3 Argentina Toll Like Receptor 8 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Toll Like Receptor 8 Revenue, 2017-2028
  6.7.2 Turkey Toll Like Receptor 8 Market Size, 2017-2028
  6.7.3 Israel Toll Like Receptor 8 Market Size, 2017-2028
  6.7.4 Saudi Arabia Toll Like Receptor 8 Market Size, 2017-2028
  6.7.5 UAE Toll Like Receptor 8 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca Plc
  7.1.1 AstraZeneca Plc Corporate Summary
  7.1.2 AstraZeneca Plc Business Overview
  7.1.3 AstraZeneca Plc Toll Like Receptor 8 Major Product Offerings
  7.1.4 AstraZeneca Plc Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Plc Key News
7.2 Celgene Corp
  7.2.1 Celgene Corp Corporate Summary
  7.2.2 Celgene Corp Business Overview
  7.2.3 Celgene Corp Toll Like Receptor 8 Major Product Offerings
  7.2.4 Celgene Corp Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.2.5 Celgene Corp Key News
7.3 Dynavax Technologies Corp
  7.3.1 Dynavax Technologies Corp Corporate Summary
  7.3.2 Dynavax Technologies Corp Business Overview
  7.3.3 Dynavax Technologies Corp Toll Like Receptor 8 Major Product Offerings
  7.3.4 Dynavax Technologies Corp Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.3.5 Dynavax Technologies Corp Key News
7.4 Eisai Co Ltd
  7.4.1 Eisai Co Ltd Corporate Summary
  7.4.2 Eisai Co Ltd Business Overview
  7.4.3 Eisai Co Ltd Toll Like Receptor 8 Major Product Offerings
  7.4.4 Eisai Co Ltd Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.4.5 Eisai Co Ltd Key News
7.5 Galderma SA
  7.5.1 Galderma SA Corporate Summary
  7.5.2 Galderma SA Business Overview
  7.5.3 Galderma SA Toll Like Receptor 8 Major Product Offerings
  7.5.4 Galderma SA Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.5.5 Galderma SA Key News
7.6 Gilead Sciences Inc
  7.6.1 Gilead Sciences Inc Corporate Summary
  7.6.2 Gilead Sciences Inc Business Overview
  7.6.3 Gilead Sciences Inc Toll Like Receptor 8 Major Product Offerings
  7.6.4 Gilead Sciences Inc Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.6.5 Gilead Sciences Inc Key News
7.7 Idera Pharmaceuticals Inc
  7.7.1 Idera Pharmaceuticals Inc Corporate Summary
  7.7.2 Idera Pharmaceuticals Inc Business Overview
  7.7.3 Idera Pharmaceuticals Inc Toll Like Receptor 8 Major Product Offerings
  7.7.4 Idera Pharmaceuticals Inc Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.7.5 Idera Pharmaceuticals Inc Key News
7.8 Janus Biotherapeutics Inc
  7.8.1 Janus Biotherapeutics Inc Corporate Summary
  7.8.2 Janus Biotherapeutics Inc Business Overview
  7.8.3 Janus Biotherapeutics Inc Toll Like Receptor 8 Major Product Offerings
  7.8.4 Janus Biotherapeutics Inc Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.8.5 Janus Biotherapeutics Inc Key News
7.9 MedImmune LLC
  7.9.1 MedImmune LLC Corporate Summary
  7.9.2 MedImmune LLC Business Overview
  7.9.3 MedImmune LLC Toll Like Receptor 8 Major Product Offerings
  7.9.4 MedImmune LLC Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.9.5 MedImmune LLC Key News
7.10 Nektar Therapeutics
  7.10.1 Nektar Therapeutics Corporate Summary
  7.10.2 Nektar Therapeutics Business Overview
  7.10.3 Nektar Therapeutics Toll Like Receptor 8 Major Product Offerings
  7.10.4 Nektar Therapeutics Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.10.5 Nektar Therapeutics Key News
7.11 Vivelix Pharmaceuticals Ltd
  7.11.1 Vivelix Pharmaceuticals Ltd Corporate Summary
  7.11.2 Vivelix Pharmaceuticals Ltd Business Overview
  7.11.3 Vivelix Pharmaceuticals Ltd Toll Like Receptor 8 Major Product Offerings
  7.11.4 Vivelix Pharmaceuticals Ltd Toll Like Receptor 8 Revenue in Global Market (2017-2022)
  7.11.5 Vivelix Pharmaceuticals Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Toll Like Receptor 8 Market Opportunities & Trends in Global Market
Table 2. Toll Like Receptor 8 Market Drivers in Global Market
Table 3. Toll Like Receptor 8 Market Restraints in Global Market
Table 4. Key Players of Toll Like Receptor 8 in Global Market
Table 5. Top Toll Like Receptor 8 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Toll Like Receptor 8 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Toll Like Receptor 8 Revenue Share by Companies, 2017-2022
Table 8. Global Companies Toll Like Receptor 8 Product Type
Table 9. List of Global Tier 1 Toll Like Receptor 8 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Toll Like Receptor 8 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Toll Like Receptor 8 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Toll Like Receptor 8 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Toll Like Receptor 8 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Toll Like Receptor 8 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Toll Like Receptor 8 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Toll Like Receptor 8 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Toll Like Receptor 8 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Toll Like Receptor 8 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Toll Like Receptor 8 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Toll Like Receptor 8 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Toll Like Receptor 8 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Toll Like Receptor 8 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Toll Like Receptor 8 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Toll Like Receptor 8 Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Plc Corporate Summary
Table 31. AstraZeneca Plc Toll Like Receptor 8 Product Offerings
Table 32. AstraZeneca Plc Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corp Corporate Summary
Table 34. Celgene Corp Toll Like Receptor 8 Product Offerings
Table 35. Celgene Corp Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 36. Dynavax Technologies Corp Corporate Summary
Table 37. Dynavax Technologies Corp Toll Like Receptor 8 Product Offerings
Table 38. Dynavax Technologies Corp Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 39. Eisai Co Ltd Corporate Summary
Table 40. Eisai Co Ltd Toll Like Receptor 8 Product Offerings
Table 41. Eisai Co Ltd Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 42. Galderma SA Corporate Summary
Table 43. Galderma SA Toll Like Receptor 8 Product Offerings
Table 44. Galderma SA Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Inc Corporate Summary
Table 46. Gilead Sciences Inc Toll Like Receptor 8 Product Offerings
Table 47. Gilead Sciences Inc Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 48. Idera Pharmaceuticals Inc Corporate Summary
Table 49. Idera Pharmaceuticals Inc Toll Like Receptor 8 Product Offerings
Table 50. Idera Pharmaceuticals Inc Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 51. Janus Biotherapeutics Inc Corporate Summary
Table 52. Janus Biotherapeutics Inc Toll Like Receptor 8 Product Offerings
Table 53. Janus Biotherapeutics Inc Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 54. MedImmune LLC Corporate Summary
Table 55. MedImmune LLC Toll Like Receptor 8 Product Offerings
Table 56. MedImmune LLC Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 57. Nektar Therapeutics Corporate Summary
Table 58. Nektar Therapeutics Toll Like Receptor 8 Product Offerings
Table 59. Nektar Therapeutics Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)
Table 60. Vivelix Pharmaceuticals Ltd Corporate Summary
Table 61. Vivelix Pharmaceuticals Ltd Toll Like Receptor 8 Product Offerings
Table 62. Vivelix Pharmaceuticals Ltd Toll Like Receptor 8 Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Toll Like Receptor 8 Segment by Type in 2021
Figure 2. Toll Like Receptor 8 Segment by Application in 2021
Figure 3. Global Toll Like Receptor 8 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Toll Like Receptor 8 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Toll Like Receptor 8 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Toll Like Receptor 8 Revenue in 2021
Figure 8. By Type - Global Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 9. By Application - Global Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 10. By Region - Global Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 11. By Country - North America Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 12. US Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 16. Germany Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 17. France Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 24. China Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 28. India Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 30. Brazil Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Toll Like Receptor 8 Revenue Market Share, 2017-2028
Figure 33. Turkey Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Toll Like Receptor 8 Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Plc Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Corp Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Dynavax Technologies Corp Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eisai Co Ltd Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Galderma SA Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences Inc Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Idera Pharmaceuticals Inc Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Janus Biotherapeutics Inc Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. MedImmune LLC Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nektar Therapeutics Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vivelix Pharmaceuticals Ltd Toll Like Receptor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)